-
EP1664045
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1664045
| EP1664045 - SUBSTITUTED DIAZABICYCLOALKANE DERIVATIVES AS LIGANDS AT ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTORS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 16.09.2011 Database last updated on 19.07.2024 | Most recent event Tooltip | 16.09.2011 | Application deemed to be withdrawn | published on 19.10.2011 [2011/42] | Applicant(s) | For all designated states ABBOTT LABORATORIES 100 Abbott Park Road Abbott Park, IL 60064-3500 / US | [N/P] |
| Former [2006/23] | For all designated states ABBOTT LABORATORIES D-377, AP6A-1, 100 Abbott Park Road Abbott Park Illinois 60064-6008 / US | Inventor(s) | 01 /
BASHA, Anwer 41 Heron Road Lake Forest, Illinois 60045 / US | 02 /
BUNNELLE, William, H. 1826 Victoria Road Mundelein, Illinois 60060 / US | 03 /
DART, Michael, J. 844 Yale Lane Highland Park, Illinois 60035 / US | 04 /
GALLAGHER, Megan, E. 2772 N. Lincoln Avenue, 205 Chicago, Illinois 60614 / US | 05 /
JI, Jianguo 1973 Sparrow Court Libertyville, Illinois 60048 / US | 06 /
PACE, Jennifer, M. 343 Stevens Court Grayslake, Illinois 60030 / US | 07 /
RYTHER, Keith, B. 862 Waterview Drive Round Lake Park, Illinois 60073 / US | 08 /
TIETJE, Karin, R. 485 Killarney Pass Circle Mundelein, Illinois 60060 / US | 09 /
MORTELL, Kathleen, H. 2018 N. Oakley Avenue Chicago, Illinois 60647 / US | 10 /
NERSESIAN, Diana, L. 4207 Coral Berry Path 103 Gurnee, Illinois 60031 / US | 11 /
SCHRIMPF, Michael, R. 327 Cambridge Drive Grayslake, Illinois 60030 / US | 12 /
LI, Tao 33524 N. Gagwood Court Grayslake, Illinois 60030 / US | [2006/23] | Representative(s) | Modiano, Micaela Nadia, et al Modiano Josif Pisanty & Staub Ltd Thierschstrasse 11 80538 München / DE | [N/P] |
| Former [2006/30] | Modiano, Micaela Nadia, et al Modiano, Josif, Pisanty & Staub Ltd., Baaderstrasse 3 80469 München / DE | ||
| Former [2006/23] | Modiano, Micaela Nadia Modiano, Josif, Pisanty & Staub Ltd., Baaderstrasse 3 80469 München / DE | Application number, filing date | 04784568.0 | 17.09.2004 | [2006/23] | WO2004US30735 | Priority number, date | US20030666884 | 19.09.2003 Original published format: US 666884 | [2006/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005028477 | Date: | 31.03.2005 | Language: | EN | [2005/13] | Type: | A1 Application with search report | No.: | EP1664045 | Date: | 07.06.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.03.2005 takes the place of the publication of the European patent application. | [2006/23] | Search report(s) | International search report - published on: | EP | 31.03.2005 | Classification | IPC: | C07D471/04, C07D487/04, C07D487/08, C07D471/08, A61K31/435, A61P25/00 | [2006/23] | CPC: |
C07D487/08 (EP,KR,US);
C07D471/08 (EP,KR,US);
A61P15/08 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P31/18 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/23] | Extension states | AL | Not yet paid | HR | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | SUBSTITUIERTE DIAZABICYCLOALKANDERIVATE ALS LIGANDEN VON ALPHA-7-NICOTINISCHEN ACETYLCHOLINREZEPTOREN | [2006/23] | English: | SUBSTITUTED DIAZABICYCLOALKANE DERIVATIVES AS LIGANDS AT ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTORS | [2006/23] | French: | DERIVES DE DIAZABICYCLOALCANE SUBSTITUES UTILISES EN TANT QUE LIGANDS AU NIVEAU DES RECEPTEURS ALPHA 7 DE L'ACETYLCHOLINE NICOTINIQUE | [2006/23] | Entry into regional phase | 29.03.2006 | National basic fee paid | 29.03.2006 | Designation fee(s) paid | 29.03.2006 | Examination fee paid | Examination procedure | 29.03.2006 | Examination requested [2006/23] | 05.04.2006 | Amendment by applicant (claims and/or description) | 19.06.2006 | Despatch of a communication from the examining division (Time limit: M06) | 29.12.2006 | Reply to a communication from the examining division | 20.03.2007 | Despatch of a communication from the examining division (Time limit: M06) | 01.10.2007 | Reply to a communication from the examining division | 13.12.2010 | Despatch of a communication from the examining division (Time limit: M04) | 27.04.2011 | Application deemed to be withdrawn, date of legal effect [2011/42] | 31.05.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/42] | Divisional application(s) | EP10175824.1 / EP2316836 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 19.06.2006 | Fees paid | Renewal fee | 08.09.2006 | Renewal fee patent year 03 | 05.09.2007 | Renewal fee patent year 04 | 27.03.2008 | Renewal fee patent year 05 | 04.09.2009 | Renewal fee patent year 06 | 07.09.2010 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO0034284 (SANOFI SYNTHELABO [FR], et al) [X] 1-28 * Claims 1-5; Formula (I); compounds 7-8, 10-11, 15-16, 37-51 and their intermediate products; p. 16, l. 5-p. 17, l. 8; p. 19, l. 8-p. 20, l. 5 *; | [X]WO0144243 (NEUROSEARCH AS [DK], et al) [X] 1-28 * Claims 1-21; Formulas (I)- (III); p. 12, l. 26-p. 14, l. 9; compounds B4 and B6 *; | [X]WO0202564 (NEUROSEARCH AS [DK], et al) [X] 1-28 * Claims 1-8, 14-24; Formula (I); p. 15, l. 6, 9, 18-29; p. 26, l. 8-12; compounds A12, C2 , F1-F7, F9-F10 and intermediate compounds; Table 2 *; | [X]WO02069901 (MERCK FROSST CANADA INC [CA], et al) [X] 1-28 * Claim 1; Formula (I); p. 135, 2nd compound *; | [X]WO02096911 (NEUROSEARCH AS [DK], et al) [X] 1-28 * Claims 1-7, 9, 11, 13-23; Formulas (I)-(V); p. 8, l. 21-22, 28, 30; p. 15, l. 35-p. 17, l. 23; compounds B2 , C1, D1, D3 *; | [PX]WO03094831 (NEUROSEARCH AS [DK], et al) [PX] 1-28 * Claims 1-28; Formula (I); p. 13, l. 23-31; compounds 1A-1F, 1H and their intermediate compounds; Tables 1 and 2 *; | [PX]WO2004009589 (BAYER HEALTHCARE AG [DE], et al) [PX] 1-28* Claims ; Formula (I); p. 40, step 4; examples 9, 15 and 17 * | Examination | WO0181347 |